Claremont BioSolutions, which makes DNA extraction technology, announced a partnership with CIA venture capital wing In‐Q‐Tel.
The relationship will help Claremont BioSolutions accelerate commercialization of gadgets that extract DNA and help parse cell types.
The battery-powered devices require a person to use a syringe to transport genetic samples into a small chamber where cells are lysed, and nucleic acids extracted within five minutes, according to the Upland, Calif.-based company. The investment will help it to bring more automation to the collection of genetic materials.
DNA testing is used to verify some immigrant visa applications and biological relationships, according to the State Department.
Addressing the 3 Biggest BYOD Security Threats
Mobile Apps: New Ways to Connect Government with Citizens
Continuous Monitoring As a Service: A Shift in the Way Government Does Business
Research Report: Powering Continuous Monitoring Through Big Data
JOIN THE DISCUSSION
By using this service you agree not to post material that is obscene, harassing, defamatory, or otherwise objectionable. Although Nextgov does not monitor comments posted to this site (and has no obligation to), it reserves the right to delete, edit, or move any material that it deems to be in violation of this rule.